The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. (Q52571988)

3 May 2018

title

The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells. (English)

1 reference

3 May 2018

1 reference

Jaroslava Lieskovska

1

1 reference

3 May 2018

Yan Ling

series ordinal

2

1 reference

3 May 2018

Jane Badley-Clarke

series ordinal

3

1 reference

3 May 2018

David R Clemmons

series ordinal

4

1 reference

3 May 2018

language of work or name

English

0 references

publication date

5 July 2006

1 reference

3 May 2018

number of pages

13

1 reference

Journal of Biological Chemistry

inferred from page(s)

published in

1 reference

3 May 2018

volume

281

1 reference

3 May 2018

issue

35

1 reference

3 May 2018

page(s)

25041-25053

1 reference

3 May 2018

Molecular and cellular aspects of the insulin-like growth factor I receptor

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

How MAP kinases are regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Src family tyrosine kinases and growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Src phosphorylates the insulin-like growth factor type I receptor on the autophosphorylation sites. Requirement for transformation by src.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for embrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Src kinase activity is required for integrin alphaVbeta3-mediated activation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

N-terminal kinase, and c-Src are activated in human aortic smooth muscle cells by pressure stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

(alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Association of c-Src with p52Shc in mitotic NIH3T3 cells as revealed by Src-Shc binding site-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Specificity of insulin-like growth factor I and insulin on Shc phosphorylation and Grb2 recruitment in caveolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Adaptor protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

VEGF-integrin interplay controls tumor growth and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

Restraining PI3K: mTOR signalling goes back to the membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602866200

21 January 2018

Identifiers

DOI

10.1074/JBC.M602866200

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugv2q5xl2bh6ngg2377ahx3x3a

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_ugv2q5xl2bh6ngg2377ahx3x3a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugv2q5xl2bh6ngg2377ahx3x3a

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/ugv2q5xl2bh6ngg2377ahx3x3a

1 reference

30 July 2022